tirzepatide and binge eating disorder New Insight: GLP‑1 medications—long used for diabetes—are now being explored for their role in care, the implications are complex. Why it matters: At much higher doses than for diabetes GLP-1 and Eating Disorders: Risks

Source: Qsymia (DailyMed), Adipex-P (DailyMed) Qsymia vs

Nausea and vomiting top the list of common side effects (36.6%), followed by diarrhea (8.6%) and fatigue (6.3%

C-peptide for Type 2 Diabetes: In contrast, Type 2 diabetes patients typically have normal or increased levels of C-peptide, which reflects insulin resistance rather than a lack of insulin production

Though DPP-4 inhibitors do not promote weight loss, they are weight neutral and can prevent further weight gain

That recalibration process can feel like generalized achiness, particularly in weight-bearing joints like the knees, hips, and lower back

Adding 2.5 mL gives a concentration of 2 mg/mL (2000 mcg/mL)